as on October 31, 2025 at 1:29 am IST
Day's Low
Day's High

1.00%
Downside
2.00%
Upside

52 Week's Low
52 Week's High

66.67%
Downside
120.00%
Upside

Check Sab Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$31.4M
EPS (TTM)
-1.945
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.60%
PE Ratio (TTM)
-0.66
Industry PE ratio
0PEG Ratio
0EBITDA
-38.5M
Revenue (TTM)
114.7K
Profit Margin
0.00%
Return On Equity TTM
-127.48%
Track how Sab Biotherapeutics Inc P/E has moved over time to understand its valuation trends.
Sab Biotherapeutics Inc in the last 5 years
Lowest (-66.91x)
March 31, 2022
Industry (0.00x)
October 30, 2025
Today (-0.66x)
October 30, 2025
Highest (-0.44x)
June 30, 2025
Today’s Price to Earnings Ratio: -0.66x
Compare market cap, revenue, PE, and other key metrics of Sab Biotherapeutics Inc with its industry peers.
| Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | 
|---|---|---|---|---|---|
| BUY | $31.4M | NA | -0.66 | 0.00% | |
| BUY | $62.4B | 291.63% | -505.15 | -12.96% | |
| NA | $36.4B | NA | NA | -3.89% | |
| BUY | $108.3B | 100.24% | 30.02 | 31.86% | |
| BUY | $69.4B | 20.12% | 15.7 | 32.13% | 
The Sab Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Sab Biotherapeutics Inc investment value today
Current value as on today
₹1,02,130
Returns
₹2,130
(+2.13%)
Returns from Sab Biotherapeutics Inc Stock
Dollar Returns*
₹5,667 (+5.67%)
Based on 8 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Sab Biotherapeutics Inc. Average target price of $8.83
Get share price movements and forecasts by analysts on Sab Biotherapeutics Inc.
What analysts predicted
66.02%UPSIDE
Target Price
$8.83
Current Price
$3
Analyzed by
8 Analysts
Target
$8.83
Sab Biotherapeutics Inc target price $8.83, a slight upside of 66.02% compared to current price of $3. According to 8 analysts rating.
Search interest for Sab Biotherapeutics Inc Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:20% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
 POSITIVE IMPACT
POSITIVE IMPACTRevenue Rich

Revenue is up for the last 2 quarters, -410.0 → 114.69K (in $), with an average increase of 100.4% per quarter
 POSITIVE IMPACT
POSITIVE IMPACTPrice Rise

In the last 1 month, SABS stock has moved up by 51.2%
 NO EFFECT
NO EFFECTAgainst Peers

In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 132.4% return, outperforming this stock by 198.6%
 NO EFFECT
NO EFFECTAgainst Peers

In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 80.6% return, outperforming this stock by 87.3%
 NEGATIVE IMPACT
NEGATIVE IMPACTProfit Down

Netprofit is down for the last 2 quarters, -5.19M → -10.11M (in $), with an average decrease of 94.6% per quarter
| Organisation | Sab Biotherapeutics Inc | 
| Headquarters | 777 W 41st St., Miami Beach, FL, United States, 33140 | 
| CEO | Mr. Samuel J. Reich | 
| E-voting on shares | Click here to vote | 
| Name | Title | 
|---|---|
| Dr. Christoph Bausch M.B.A., Ph.D. | Executive VP & COO | 
| Dr. Alexandra Kropotova M.B.A., M.D. | Executive VP & Chief Medical Officer | 
| Ms. Hua Wu Ph.D. | Senior Vice President of Product Development | 
| Dr. Carlos N. Carillo M.Sc., Ph.D. | Senior Vice President of Regulatory Affairs | 
| Ms. Angie Parizek | Senior Vice President of Clinical Operations | 
| Mr. Samuel J. Reich | Chairman & CEO | 
| Dr. Eddie Joe Sullivan Ph.D. | Co-Founder, President & Director | 
| Ms. Lucy To | Executive VP & CFO | 
| Ms. Catherine DeRose | Vice President of Human Resources | 
Sab Biotherapeutics Inc share price today is $3 as on at the close of the market. Sab Biotherapeutics Inc share today touched a day high of $3.06 and a low of $2.97.
Sab Biotherapeutics Inc share touched a 52 week high of $6.6 on and a 52 week low of $1 on . Sab Biotherapeutics Inc stock price today i.e. is closed at $3,which is 54.55% down from its 52 week high and 200.00% up from its 52 week low.
Sab Biotherapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Sab Biotherapeutics Inc (SABS) shares with as little as ₹88.686 or $1 (as of ) using the INDmoney app. 
      
      For example: If you want to invest $10 or ₹886.86 in Sab Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). 
        Based on Sab Biotherapeutics Inc share’s latest price of $3 as on October 31, 2025 at 1:29 am IST, you will get 3.3333 shares of Sab Biotherapeutics Inc. Learn more about
          
            fractional shares .